BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose

This publication has 56 references indexed in Scilit:

• Structure-guided design of a selective BCL-XL inhibitor
  Nature Chemical Biology, 2013
• Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
  Nature Cell Biology, 2012
• Comparative Metabolic Flux Profiling of Melanoma Cell Lines
  Journal of Biological Chemistry, 2011
• Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase
  Nature Cell Biology, 2011
• Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8
  Cell Death & Differentiation, 2011
• Assessing mitochondrial dysfunction in cells
  Biochemical Journal, 2011
• Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome‐c release
  Molecular Systems Biology, 2011
• Hallmarks of Cancer: The Next Generation
  Cell, 2011
• Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators
  Proceedings of the National Academy of Sciences, 2009
• Bcl-xL forms an ion channel in synthetic lipid membranes
  Nature, 1997